Smead Capital (MAC) reports 12.16M shares, holding 4.74% in Macerich
Rhea-AI Filing Summary
Smead Capital Management filed an amendment reporting beneficial ownership of 12,155,332.57 shares of Macerich Company common stock, representing 4.74% of the class. The filing is a joint Schedule 13G/A amendment signed by Smead Capital, William W. Smead, and Cole W. Smead.
The report lists sole voting and dispositive power over 12,155,332.57 shares and provides the issuer's principal office address in Santa Monica, California.
Positive
- None.
Negative
- None.
Insights
Large passive stake reported: Smead holds 4.74% of Macerich.
The amendment records 12,155,332.57 shares beneficially owned with sole voting and dispositive power. As a Schedule 13G/A filing, this typically indicates an investment manager reporting a passive position rather than an active acquisition intent.
Materiality depends on context: the 4.74% stake is below the 5% threshold that often triggers different disclosure regimes. Subsequent filings could change the picture if ownership crosses regulatory thresholds.
Filing appears procedurally complete and joint.
The form includes a joint filing statement under Rule 13d-1(k) and signatures from the CI0, CEO, and Chief Compliance Officer. It lists CUSIP 554382101 and the issuer address verbatim.
Investors seeking changes in control or voting coordination should watch for any future amendments that alter percent ownership or disclose coordinated activity.